| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6248995 | Transplantation Proceedings | 2011 | 5 Pages |
Abstract
The antiviral treatment combination using PEG-IFN and RIB for recurrent hepatitis C is effective procedure. The SVR of 33% after 12 months of treatment with significant improvement in HAI grading and staging and stable HAI in all treated patients favor early initiation and 12-month administration of antiviral treatment. Furthermore, all patients with BR without VR, who underwent antiviral treatment for a further 6 months, achieved a VR. However, the optimal duration of treatment needs to be investigated in large prospective studies.
Related Topics
Health Sciences
Medicine and Dentistry
Surgery
Authors
A. Perrakis, S. Yedibela, S. Schuhmann, R. Croner, V. Schellerer, R. Demir, W. Hohenberger, V. Müller,